Immature Immunoglobulin Gene Rearrangements Are Recurrent in B Precursor Adult Acute Lymphoblastic Leukemia Carrying TP53 Molecular Alterations.
Silvia SalmoiraghiRoberta CavagnaMarie Lorena Guinea MontalvoGreta UbialiManuela TosiBarbara PerutaTamara IntermesoliElena OldaniAnna SalviChiara PavoniUrsula GiussaniRenato BassanAlessandro RambaldiOrietta SpinelliPublished in: Genes (2020)
Here, we describe the immunoglobulin and T cell receptor (Ig/TCR) molecular rearrangements identified as a leukemic clone hallmark for minimal residual disease assessment in relation to TP53 mutational status in 171 Ph-negative Acute Lymphoblastic Leukemia (ALL) adult patients at diagnosis. The presence of a TP53 alterations, which represents a marker of poor prognosis, was strictly correlated with an immature DH/JH rearrangement of the immunoglobulin receptor (p < 0.0001). Furthermore, TP53-mutated patients were classified as pro-B ALL more frequently than their wild-type counterpart (46% vs. 25%, p = 0.05). Although the reasons for the co-presence of immature Ig rearrangements and TP53 mutation need to be clarified, this can suggest that the alteration in TP53 is acquired at an early stage of B-cell maturation or even at the level of pre-leukemic transformation.
Keyphrases
- acute lymphoblastic leukemia
- poor prognosis
- early stage
- wild type
- long non coding rna
- acute myeloid leukemia
- end stage renal disease
- newly diagnosed
- allogeneic hematopoietic stem cell transplantation
- ejection fraction
- chronic kidney disease
- radiation therapy
- gene expression
- lymph node
- genome wide
- squamous cell carcinoma
- neoadjuvant chemotherapy
- anti inflammatory
- clinical evaluation